<table border="0" cellpadding="4" id="SPLSERV-0441f3ef-d8dc-1e66-eb0a-035ad08851e5" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="SPLSERV-5c135250-069c-2fe3-193f-d850442f30c5">Table 16. Mean Pharmacokinetic Parameters in Pediatric Subjects With Epilepsy</caption>
<colgroup>
<col width="30%"></col>
<col width="17.5%"></col>
<col width="17.5%"></col>
<col width="17.5%"></col>
<col width="17.5%"></col>
</colgroup>
<tbody>
<tr id="SPLSERV-56ff2cf2-e455-cf8b-fdc8-44da62e4ee28">
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="middle">
<content stylecode="bold">Pediatric Study Population</content>
</td>
<td align="center" stylecode="Botrule Rrule Toprule" valign="middle">
<content stylecode="bold">Number of <br/>Subjects</content>
</td>
<td align="center" stylecode="Botrule Rrule Toprule" valign="middle">
<content stylecode="bold">T<sub>max</sub>  (h)</content>
</td>
<td align="center" stylecode="Botrule Rrule Toprule" valign="middle">
<content stylecode="bold">t<sub>½</sub>  (h)</content>
</td>
<td align="center" stylecode="Botrule Rrule Toprule" valign="middle">
<content stylecode="bold">CL/F <br/>(mL/min/kg)</content>
</td>
</tr>
<tr id="SPLSERV-559bc25b-1625-2dc0-3ea4-1a18901f5dce">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Ages 10 months-5.3 years</content>
</td>
<td align="left" stylecode="Rrule" valign="middle">  </td>
<td align="left" stylecode="Rrule" valign="middle">  </td>
<td align="left" stylecode="Rrule" valign="middle">  </td>
<td align="left" stylecode="Rrule" valign="middle">  </td>
</tr>
<tr id="SPLSERV-27ae2616-e57f-d0fa-a075-afb0894ce4e9">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="SPLSERV-a1d16378-a161-e137-ea45-9aa985a5b121">Carbamazepine, phenytoin, phenobarbital, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives, rifampin, and the protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir have also been shown to increase the apparent clearance of lamotrigine <content stylecode="italics">[see Drug Interactions (<linkhtml href="#ID_5c10c3bb-3727-0069-e02c-a50729b3f488">7</linkhtml>)]</content>.</footnote>
</td>
<td align="center" stylecode="Rrule" valign="top">10 </td>
<td align="center" stylecode="Rrule" valign="top">3.0 <br/>(1.0<content stylecode="bold">-</content> 5.9) </td>
<td align="center" stylecode="Rrule" valign="top">7.7 <br/>(5.7<content stylecode="bold">-</content> 11.4) </td>
<td align="center" stylecode="Rrule" valign="top">3.62 <br/>(2.44<content stylecode="bold">-</content> 5.28) </td>
</tr>
<tr id="SPLSERV-f92453ea-5379-b18e-5736-83966d017e69">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking AEDs with no  known effect on the apparent clearance of lamotrigine</td>
<td align="center" stylecode="Rrule" valign="top">7 </td>
<td align="center" stylecode="Rrule" valign="top">5.2 <br/>(2.9<content stylecode="bold">-</content> 6.1) </td>
<td align="center" stylecode="Rrule" valign="top">19.0 <br/>(12.9<content stylecode="bold">-</content> 27.1) </td>
<td align="center" stylecode="Rrule" valign="top">1.2 <br/>(0.75<content stylecode="bold">-</content> 2.42) </td>
</tr>
<tr id="SPLSERV-2a4fbade-9f67-33ee-0f24-49ec21556ad1">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">Subjects taking valproate only</td>
<td align="center" stylecode="Botrule Rrule" valign="top">8 </td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.9 <br/>(1.0<content stylecode="bold">-</content> 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">44.9 <br/>(29.5<content stylecode="bold">-</content> 52.5) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">0.47 <br/>(0.23<content stylecode="bold">-</content> 0.77) </td>
</tr>
<tr id="SPLSERV-c402334c-8e29-f044-df29-d4d6f6689184">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Ages 5-11 years</content>
</td>
<td align="center" stylecode="Rrule" valign="middle">  </td>
<td align="center" stylecode="Rrule" valign="middle">  </td>
<td align="center" stylecode="Rrule" valign="middle">  </td>
<td align="center" stylecode="Rrule" valign="middle">  </td>
</tr>
<tr id="SPLSERV-15cf00fe-b378-2215-6a48-77fbeab1ae9d">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="SPLSERV-a1d16378-a161-e137-ea45-9aa985a5b121"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="top">7 </td>
<td align="center" stylecode="Rrule" valign="top">1.6 <br/>(1.0<content stylecode="bold">-</content> 3.0) </td>
<td align="center" stylecode="Rrule" valign="top">7.0 <br/>(3.8<content stylecode="bold">-</content> 9.8) </td>
<td align="center" stylecode="Rrule" valign="top">2.54 <br/>(1.35<content stylecode="bold">-</content> 5.58) </td>
</tr>
<tr id="SPLSERV-4ce812af-4b88-4467-ed30-186b59bb8b2b">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="SPLSERV-a1d16378-a161-e137-ea45-9aa985a5b121"></footnoteref>   plus valproate </td>
<td align="center" stylecode="Rrule" valign="top">8 </td>
<td align="center" stylecode="Rrule" valign="top">3.3 <br/>(1.0<content stylecode="bold">-</content> 6.4) </td>
<td align="center" stylecode="Rrule" valign="top">19.1 <br/>(7.0<content stylecode="bold">-</content> 31.2) </td>
<td align="center" stylecode="Rrule" valign="top">0.89 <br/>(0.39<content stylecode="bold">-</content> 1.93) </td>
</tr>
<tr id="SPLSERV-dddf3344-dabb-bb0f-0e4f-2221db590f7f">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">Subjects taking valproate only<footnote id="SPLSERV-381d4a16-189b-bc68-5710-96e6187a5f35">Two subjects were included in the calculation for mean T<sub>max</sub>.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">3 </td>
<td align="center" stylecode="Botrule Rrule" valign="top">4.5 <br/>(3.0<content stylecode="bold">-</content> 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">65.8<br/> (50.7<content stylecode="bold">-</content> 73.7) </td>
<td align="center" stylecode="Botrule Rrule" valign="top">0.24 <br/>(0.21<content stylecode="bold">-</content> 0.26) </td>
</tr>
<tr id="SPLSERV-0928e6eb-c6c5-9404-daf0-4fa21ff9fd5e">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Ages 13-18 years</content>
</td>
<td align="center" stylecode="Rrule" valign="top">  </td>
<td align="center" stylecode="Rrule" valign="top">  </td>
<td align="center" stylecode="Rrule" valign="top">  </td>
<td align="center" stylecode="Rrule" valign="top">  </td>
</tr>
<tr id="SPLSERV-c938c465-2678-9cde-8f31-231c34926e3f">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="SPLSERV-a1d16378-a161-e137-ea45-9aa985a5b121"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="top">11 </td>
<td align="center" stylecode="Rrule" valign="top">
<footnote id="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2">Parameter not estimated.</footnote>
</td>
<td align="center" stylecode="Rrule" valign="top">
<footnoteref idref="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="top">1.3 </td>
</tr>
<tr id="SPLSERV-eb5d4994-3efd-4c26-ede0-6a15015f3ba5">
<td align="left" stylecode="Lrule Rrule" valign="top">Subjects taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="SPLSERV-a1d16378-a161-e137-ea45-9aa985a5b121"></footnoteref>   plus valproate </td>
<td align="center" stylecode="Rrule" valign="top">8 </td>
<td align="center" stylecode="Rrule" valign="top">
<footnoteref idref="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="top">
<footnoteref idref="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="top">0.5 </td>
</tr>
<tr id="SPLSERV-4ee0d704-4315-64cd-4a31-9e1dc97da979">
<td align="left" stylecode="Botrule Lrule Rrule" valign="top">Subjects taking valproate only </td>
<td align="center" stylecode="Botrule Rrule" valign="top">4 </td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<footnoteref idref="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<footnoteref idref="SPLSERV-cd484b2c-bcfd-eac5-b82e-fcb0759e8ae2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">0.3 </td>
</tr>
</tbody>
</table>